Thymosin and the Spontaneously Diabetic BB Rat

References

• Like AA, Butler L, Williams RM, Appel MC, Weringer EJ, Rossini AA. Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes 1982; 31: 7–13, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Marliss EB, Nakhooda AF, Poussier P, Sima AAF. The diabetic syndrome of the “BB” Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia 1982; 22: 225–32
   PubMed Web of Science ®Google Scholar
• Cahill G, McDevitt HO. Insulin dependent diabetes mellitus the initial lesion. New England Journal of Medicine 1981; 304: 1454–65
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS. Type 1 diabetes, mellitus, a chronic autoimmune, disease. New England Journal of Medicine 1986; 314: 1360–8
   PubMed Web of Science ®Google Scholar
• Maclaren NK, Riley WJ. Thyro-gastric autoimmuities and insulin dependent diabetes. Diabetes Care 1985; 8: 34–8, Suppl
   PubMedGoogle Scholar
• Sternthal E, Like AA, Sarantis K, Braverman LE. Lymphocytic thydroiditis and diabetes in the BB/W rat. Diabetes 1982; 30: 1058–61
   Google Scholar
• Jackson RN, Rassi N, Crump T, Haynes B, Eisenbarth GS. The BB diabetic rat: profound T-cell lymphocytopenia. Diabetes 1981; 30: 887–9
   PubMed Web of Science ®Google Scholar
• Elder ME, Maclaren NK. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. Journal of Immunology 1983; 130: 1723–31
   PubMed Web of Science ®Google Scholar
• Poussier PAF, Nakhooda JA, Lee FC, Marliss EB. Lymphopenia and abnormal lymphocyte subsets in “BB” rat: relationship to the diabetic syndrome. Endocrinology 1982; 110: 1825–7
   PubMedGoogle Scholar
• Ammann AJ. Immunodeficiency disorders and autoimmunity. Autoimmunity 1977; 479–512
   Google Scholar
• Hersh EM, Reuben JM, Rios A, Mansell PWA, Newell GR, McClure JE, Goldstein AL. Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sacroma. New England Journal of Medicine 1983; 308: 45–6
   Google Scholar
• Biggar RJ, Taylor PH, Goldstein AL, Melbye M, Ebbesen P, Mann DL, Strong DM. Thymosin alpha 1 levels and helper: suppressor ratios in homosexual men. New England Journal of Medicine 1983; 309: 49
   Google Scholar
• Dardenne M, Safai B. Low serum thymic hormone levels in patients with acquired immunodeficiency syndrome. New England Journal of Medicine 1983; 309: 48–9
   PubMed Web of Science ®Google Scholar
• Bach JF. Thymic hormones. Journal of Immunopharmacology 1979; 1: 277–310
   Google Scholar
• Goldstein AL, Low TLK, Thurman GB, Zatz MM, Hall N, Chen J, Hu S-K., Naylor PB, McClure JE. Current status of thymosin and other hormones of the thymus gland. Recent Progress of Hormone Research 1981; 37: 369–415
   PubMedGoogle Scholar
• Trainin N, Pecht M, Handzel ZT. Thymic hormones: inducers and regulators of the T-cell system. Immunology Today 1983; 4: 16–21
   PubMedGoogle Scholar
• Wara DW. Thymic hormones and the immune system. Advances in Pediatrics 1981; 28: 229–70
   PubMedGoogle Scholar
• Goldstein AL, Hooper JA, Schulof RS, Cohen GH, Thurman GB, McDaniel MC, White A, Dardenne M. Thymosin and the immunopathology of aging. Federation Proceedings 1974; 33: 2053–6
   Google Scholar
• McClure JE, Lameris N, Wara DW, Goldstein AL. Immunochemical studies on thymosin: radioimmunoassay of thymosin alpha 1. Journal of Immunol 1982; 128: 368–75
   PubMed Web of Science ®Google Scholar
• Marliss EB. Recommended nomenclature for the sponateously diabetic syndrome in the BB rat. Metabolism 1983; 32: 6–7
   Google Scholar
• Goldstein AL, Guha A, Zatz MM, Hardy MA, White A. Purification and biological activity of, thymosin, a hormone of the thymus, gland. Proceedings of the National Academy of Sciences 1972; 69: 1800–3
   PubMed Web of Science ®Google Scholar
• Barrett DJ, Wara DW, Ammann AJ, Cowan MJ. Thymosin therapy in the DiGeorge syndrome. Journal of Pediatrics 1980; 97: 66–71
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Cohen GH, Rossio JL, Thurman GB, Brown CN, Ulrich JI. Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Medical Clinics of North America 1976; 60: 591–606
   PubMed Web of Science ®Google Scholar
• Rubinstein A, Hirschhorn R, Sicklick M, Murphy RA. In vivo and in vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes. New England Journal of Medicine 1979; 300: 387–92
   Google Scholar
• Marshall GD, Low TLK, Thurman GB, Goldstein AL. Recent advances in thymosin research. Human Lymphocyte Differentiation: Its Application to Cancer. INSERM Sym No. 8, B Serrou, C Rosenfeld. Elsevier/North Holland Biomedical Press, Amsterdam 1978; 271–7
   Google Scholar
• Naot Y, Merchav S, Ginsburg H. Mycoplasma neurolyticum: a potent mitogen for rat B lymphocytes. European Journal of Immunology 1979; 9: 185–9
   PubMedGoogle Scholar
• Naot Y, Merchav S, Ben-David E, Ginsburg H. Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes. Immunology 1979; 36: 399–406
   Google Scholar
• Elder M, Maclaren N, Riley W, McConnel T. Gastric parietal cell and other autoantibodies in the BB rat. Diabetes 1982; 31: 313–8
   PubMed Web of Science ®Google Scholar
• Quiniou-Debrie MC, Debray-Sachs M, Dardenne M, Czernichow P, Assan R, Bach JF. Anti-islet cellular and humoral, immunity, T-cell, subsets, and thymic function in type 1, diabetes. Diabetes 1985; 34: 373–9
   PubMed Web of Science ®Google Scholar
• Woda BA, Like AA, Padden C, McFadden ML. Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol 1986; 35: 110–4
   Google Scholar
• Bordigoni P, Faure G, Bene MC, Dardenne M, Bach JF, Duheille J, Olive D. Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS). Lancet 1982; 2: 293–7
   Google Scholar
• Wara DW, Goldstein AL, Doyle NE, Ammann AJ. Thymosin activity in patients with cellular immunodeficiency. New England Journal of Medicine 1975; 292: 70–4
   PubMed Web of Science ®Google Scholar
• Horowitz S, Borcherding W, Moorthy AV, Chesney R, Schulte-Wissermann H, Hong R, Goldstein A. Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science 1977; 197: 999–1001
   PubMed Web of Science ®Google Scholar
• Scheinberg MA, Cathcart ES, Goldstein AL. Thymosin-induced reduction of “null cells” in peripheral-blood lymphocytes of patients with systemic lupus erythematosus. Lancet 1975; 1: 424–6
   PubMed Web of Science ®Google Scholar
• Moutsopoulos H, Fye KH, Sawada S, Becker MJ, Goldstein A, Talal N. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases. Clinical & Experimental Immunology 1976; 26: 563–73
   Google Scholar
• Lavastida MT, Goldstein AL, Daniels JC. Thymosin administration in autoimmune disorders. Thymus 1981; 2: 287–95
   PubMedGoogle Scholar
• Wara DW, Barrett DJ, Ammann AJ, Cowan MJ. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease. Annals of the New York Academy of Sciences 1979; 332: 128–34
   Google Scholar
• Gershwin ME, Ahmed A, Steinberg AD, Thurman GB, Goldstein AL. Correction of T cell function by thymosin in New Zealand mice. Journal of Immunology 1974; 113: 1068–71
   Google Scholar
• Talal N, Dauphinee M, Pillarisetty R, Goldblum R. Effect of thymosin on thymocyte proliferation and autoimmunity in NZB mice. Annals of the New York Academy of Sciences 1975; 249: 438–49
   PubMedGoogle Scholar
• Ba D, Takeichi N, Kodama T, Kobayashi H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. Journal of Immunology 1982; 128: 1211–6
   PubMed Web of Science ®Google Scholar
• Takeichi N, Koga Y, Fujii T, Kobayashi H. Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5. Cancer Research 1985; 45: 487–91
   Google Scholar
• Dabrowski MP, Goldstein AL. Thymosin induced changes in the cell cycle of lymphocytes from aging neonatally thymectomized rats. Immunological Communications 1976; 5: 695–704
   PubMed Web of Science ®Google Scholar
• Trainin N. Thymic hormones and the immune response. Physiological Reviews 1974; 54: 272–306
   PubMed Web of Science ®Google Scholar
• Like AA, Guberski DL, Butler L. Diabetic biobreeding/Worcester (BB/Wor) rats need not be lymphopenic. Journal of Immunology 1986; 136: 3254–8
   PubMedGoogle Scholar
• Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA. Absence of RT-6 T cell subset in diabetes-prone BB/W rats. Journal of Immunology 1986; 136: 148–151
   PubMed Web of Science ®Google Scholar
• Wara DW, Ammann AJ. Effect of thymosin on B-lymphocyte function. New England Journal of Medicine 1979; 293: 507
   Google Scholar
• Mingari MC, Gerosa F, Carra G, Accolla RS, Moretta A, Zubler RH, Waldmann TA, Moretta L. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984; 312: 641–3
   PubMed Web of Science ®Google Scholar
• Francfort JW, Naji A, Silvers WK, Barler CF. The influence of T-lymphocyte precursor cells and thymus grafts on the cellular immunodeficiences of the BB rat. Diabetes 1985; 34: 1134–8
   Google Scholar
• Laskin CA, Smathers PA, Reeves JP, Steinberg AD. Studies of defective tolerance induction in NZB, mice, evidence for a marrow pre-T cell, defect. Journal of Experimental Medicine 1982; 155: 1025–35
   Google Scholar
• Prud'homme GJ, Freks A, Lolle E, Sumagers TS, Gruttman RD. Immune dysfunction in diabetes-prone BB rats: interleukin-2 production and other mitogen-induced responses are suppressed by activated macrophages. Journal of Experimental Medicine 1984; 159: 463–78
   PubMed Web of Science ®Google Scholar
• Woda BA, Padden C. Mitogen responsiveness of lymphocytes from the BB/W rat. Diabetes 1986; 35: 513–6
   Google Scholar